Ebastine

Chemical formula: C₃₂H₃₉NO₂  Molecular mass: 469.658 g/mol  PubChem compound: 3191

Active ingredient description

Ebastine has been shown to produce a rapid and long-lasting inhibition of histamine-induced effect and to have a strong affinity towards H1-receptors.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
R06AX22 Ebastine R Respiratory system → R06 Antihistamines for systemic use → R06A Antihistamines for systemic use → R06AX Other antihistamines for systemic use
Discover more medicines within R06AX22

Product monographs

Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):

Title Information Source Document Type  
EBASTEL Film-coated tablet Υπουργείο Υγείας (CY) MPI, EU: SmPC
EBASTINE Oral orodispersible tablet MPI, EU: SmPC

Structural formula

Graphic representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 90729-43-4
DrugBank Drug: DB11742
PubChem Compound: 3191
RxNorm Ingredient: 23796
SNOMED-CT Concept: 697997002
Ebastine (substance)
UNII Identifier: TQD7Q784P1
EBASTINE

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.